LncRNA在食管癌诊疗中的研究进展
摘要
关键词
全文:
PDF参考
[1]Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin. 2024,74(3):229-263.
[2]Cable J, Heard E, Hirose T, et al. Noncoding RNAs: biology and applications-a Keystone Symposia report[J]. Ann N Y Acad Sci.2021,1506(1):118-141.
[3]毕昕,牛中喜,闫睿等.血清miR-183-3p、miR-495-3p表达与食管癌患者临床病理特征及预后的关系[J].疑难病杂志,2024,23(7):769-774.
[4]索美芳,郭冬芳,申国庆.食管癌中长链非编码RNA-UCA1表达与其临床病理特征及预后的关系[J].实验与检验医学,2023,41(06):776-779.
[5]杨珍珍,高娜,宋银森等.长链非编码RNACASC8在食管癌组织中的表达及临床意义[J].食管疾病,2024,6(01):18-23.
[6]Zhang Y, Chen C, Liu Z, et al. PABPC1-induced stabilization of IFI27 mRNA promotes angiogenesis and malignant progression in esophageal squamous cell carcinoma through exosomal miRNA-21-5p[J]. Exp Clin Cancer Res. 2022,41(1):111.
[7]张健,邵生辉,彭雅琼等.沉默长链非编码RNAANO1-AS1对食管鳞癌细胞迁移、侵袭的影响[J].中国老年学杂志,2024,44(01):75-81.
[8]周超锋,周世繁,田青等.lncRNA-NORAD表达对食管癌Eca-109细胞生物学行为的影响及其机制[J].吉林大学学报(医学版),2022,48(01):33-43.
[9]Xue ST, Zheng B, Cao SQ, et al. Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis[J]. Mol Cancer. 2022,21(1):69.
[10]Gao N, Jiang G, Gao Z, et al. Long non-coding RNA LINC00707, a prognostic marker, regulates cell proliferation, apoptosis, and EMT in esophageal squamous cell carcinoma[J]. Am J Transl Res.2023,15(4):2426-2442.
[11]Luo XJ, He MM, Liu J, et al. LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription[J].Exp Mol Med. 2022,54(6):834-847.
[12]Tang J, Xu H, Liu Q, et al. LncRNA LOC146880 promotes esophageal squamous cell carcinoma progression via miR-328-5p/FSCN1/MAPK axis[J]. Aging (Albany NY). 2021,13(23):25602-25603.
[13]Chen Z, Tang W, Ye W, et al. ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer[J]. Cell Cycle. 2022,21(16):1710-1725.
[14]Hu R, Bi R, Jiang L, et al. LncRNA TUSC8 suppresses the proliferation and migration of esophageal cancer cells by downregulation of VEGFA[J]. Cancer. 2021,12(21):6393-6400.
[15]Su W, Guo C, Wang L, et al. LncRNA MIR22HG abrogation inhibits proliferation and induces apoptosis in esophageal adenocarcinoma cells via activation of the STAT3/c-Myc/FAK signaling[J]. Aging (Albany NY). 2019,11(13):4587-4596.
[16]Nan Y, Luo Q, Wu X, et al. HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity[J]. Mol Ther.2023,31(2):552-568.
[17]Gao N, Jiang G, Gao Z, et al. Long non-coding RNA LINC00707, a prognostic marker, regulates cell proliferation, apoptosis, and EMT in esophageal squamous cell carcinoma[J]. Am J Transl Res.2023,15(4):2426-2442.
[18]Wang H, Li H, Yu Y, et al. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression[J]. Cell Cycle. 2021,20(1):39-53.
[19]Yang R, Wan J, Ma L, et al. TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis[J]. Cell Death Discov.2023,9(1):431.
[20]Cheng W, Yang F, Ma Y et al. lncRNA TPT1-AS1 promotes cell migration and invasion in esophageal squamous-cell carcinomas by regulating the miR-26a/HMGA1 axis[J]. Open Med (Wars).2023 Feb 14;18(1):20220533.
[21]刘硕,刘志坚,毛逸琪,等.血清Linc01503在食管鳞状细胞癌中的表达及鉴别诊断价值[J].临床检验杂志,2022,40(09):685-687.
[22]刘倩.基于G四链体DNA-硫黄素T反应诱导的荧光增强无标记检测癌细胞中的lncRNA[D].济南:山东师范大学,2022.
[23]王鹏雨.等温扩增检测蛋白激酶和长链非编码RNA的研究[D].济南:山东师范大学,2023.
[24]Xue W, Shen Z, Li L, et al. Long non-coding RNAs MACC1-AS1 and FOXD2-AS1 mediate NSD2-induced cisplatin resistance in esophageal squamous cell carcinoma[J]. Mol Ther Nucleic Acids.2020,23:592-602.
[25]王伟,何天乐,李扬,等.lncRNACASC11通过EZH2调控PI3K/AKT通路促进食管鳞癌细胞顺铂耐药的机制研究[J].现代肿瘤医学.2023,31(14):2624-2631.
[26]Jia Y, Tian C, Wang H, et al. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin[J]. Mol Cancer. 2021,20(1):162.
[27]Ye C, Xu C, Tang Y, et al. A novel disulfidptosis-related LncRNA prognostic risk model: predicts the prognosis, tumor microenvironment and drug sensitivity in esophageal squamous cell carcinoma[J]. BMC Gastroenterol. 2024,24(1):437.
[28]Cao S, Wang X, Liu X, et al. Integrative Analysis of Angiogenesis-Related Long Non-Coding RNA and Identification of a Six-DEARlncRNA Signature Associated with Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma[J]. Cancers (Basel). 2022;14(17):4195.
[29]Fu X, Chen X, Si Y, et al. Long non-coding RNA NCK1-AS1 is overexpressed in esophageal squamous cell carcinoma and predicts survival[J]. Bioengineered. 2022,13(4):8302-8310.
[30]Nan Y, Luo Q, Wu X, et al. HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity[J]. Mol Ther. 2023,31(2):552-568.
[31]王静.启膈散通过LncRNA MEG3上调PTEN增加食管癌细胞对顺铂的敏感性研究[D].郑州:河南中医药大学,2023.
(0 摘要 Views, 0 PDF Downloads)
Refbacks
- 当前没有refback。